Obsessive-Compulsive Disorder Clinical Trial
Official title:
Effect of Stepped Care in Internet-Based Cognitive Behavioral Therapy for Adults With Obsessive-Compulsive Disorder:A Three-Arm Randomized Controlled Trial
The goal of this clinical trial is to learn about the efficacy and cost-effectiveness of stepped-care Internet-based cognitive behavioral therapy (SC-ICBT) compared with Cognitive Behavioral Group Therapy (CBGT) and conventional medical treatment (treatment as usual, TAU) in adults with obsessive-compulsive disorder (OCD) in China. The main questions it aims to answer are: question 1: Whether the efficacy of SC-ICBT is noninferior to CBGT and TAU for OCD? question 2: Whether SC-ICBT is more cost-effective than CBGT and TAU for OCD? Participants will receive treatment (SC-ICBT or CBGT or TAU) for 6 weeks. Prior to the main study, we conduct a non-randomized pilot study to explore the efficacy and cost-effectiveness of SC-ICBT related to CBGT for adults with OCD in China.
Status | Recruiting |
Enrollment | 114 |
Est. completion date | June 30, 2025 |
Est. primary completion date | January 30, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 50 Years |
Eligibility | Inclusion Criteria: 1. Age between 18 and 50 years 2. Satisfied with the diagnostic criteria for OCD in DSM-5. 3. 16=YBOCS score =31 4. Taking medication stably for 8 weeks 5. Education level ?6 years 6. Has sufficient audiovisual skills to complete the necessary examinations for the study. 7. Right-handed (this criterion is for fMRI subjects only) 8. Subjects and their guardians understood the study and signed informed consent. Exclusion Criteria: 1. Satisfied with the diagnostic criteria for a mental disorder in DSM-V other than OCD. 2. Obsessive-compulsive symptoms were too severe to participate in the experiment. 3. High risk of suicide. 4. Severe central system or physical disease 5. Pregnant women or women that getting ready for being pregnant and lactating. 6. Other treatments being performed. 7. Uncooperative or unable to complete treatment 8. With metal implants in the body, such as pacemakers, intracranial silver clips, metal dentures, arterial stents, arterial clips, joint metal fixation, or other metal implants, etc. (this criterion is for fMRI subjects only) |
Country | Name | City | State |
---|---|---|---|
China | Shanghai Mental Health Center | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Shanghai Mental Health Center |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change of 36-item Short Form Health Survey(SF-36) | 36-item Short Form Health Survey(SF-36)will be used to assess the health-related quality of life of patients. SF-36 is one of the most commonly used standardized measurement tools for quality of life in the world, including eight subscales, a total of 36 items, involving physical and mental health. | Change from Baseline at 6weeks | |
Other | Cost-effectiveness analysis | The study designs a self-rated questionnaire about cost-effectiveness analyses, including both direct and indirect costs, and the patients themselves fill out the questionnaire based on the bill.
The cost-effectiveness analysis method (CEA) is used to measure the spending of three groups. The results of the total cost divided by YBOCS total reduction scores can reflect the cost required to obtain each unit of curative effect. |
the cost from Baseline to Week 6 | |
Other | Cost-utility analysis | The cost-utility analysis method is used to measure the spending of improving patients' quality of life. The results of the total cost divided by SF-36 total improvement scores can reflect the cost required to obtain each unit of utility. | the cost from Baseline to Week 6 | |
Other | Dropout rate | Dropout rate is recorded to evaluate treatment acceptability. | From Baseline to Week 6 | |
Other | Frequency of occurrence | Frequency of occurrence is recorded to evaluate treatment acceptability. The investigators use sign-in sheets to measure patients' attendance during the treatment. | From Baseline to Week 6 | |
Other | Homework completion | Homework completion is recorded to evaluate treatment acceptability. The investigators use sign-in sheets to keep track of patients' homework completion. | From Baseline to Week 6 | |
Other | Subjective satisfaction with treatment | Subjective satisfaction with treatment is recorded to evaluate treatment acceptability. The investigators use a self-rated question("Overall, how satisfied are you with your current treatment?") to measure patients' subjective satisfaction. The rating was done on a 7-item scale ranging from "Extremely dissatisfied" to "Extremely satisfied". | From Baseline to Week 6 | |
Other | Treatment safety | Adverse events (AEs) are the treatment safety indicators | From Baseline to Week 6 | |
Other | Change of randomized dot motion(RDM) perceptual decision-making task | RDM is a classical perceptual decision paradigm, in which subjects need to report the overall movement direction of 300 randomly moving white dots, and the total duration of the task is about 25 minutes. RDM is often used together with drift diffusion models to study human decision-making processes and has been supported by many research evidences. After the RDM decision, a confidence assessment stage is added to measure the decision confidence of the subjects through their subjective reports. | Change from Baseline at 6weeks | |
Other | Change of the antisaccade task | The antisaccade task is a classical experimental paradigm to measure the response inhibition ability of subjects in the field of cognitive function. | Change from Baseline at 6weeks | |
Other | Change of the task-state functional magnetic resonance imaging(fMRI) of the whole brain | The investigators use the randomized dot motion perceptual decision-making task as Neuroimaging Paradigm to observe the neurophysiological changes cauesd by step-ICBT in patients with OCD. | Change from Baseline at 6weeks | |
Primary | Change of Yale-Brown Obsessive-Compulsive Scale (YBOCS) | YBOCS is compiled by Goodman in the United States and contains 10 items to assess the severity of obsessive thoughts and compulsive behavior. The scoring method adopts a five-point scale of 0-4 points, and the total score range is 0-40 points, which has good reliability and validity. | Change from Baseline at 6weeks | |
Secondary | Change of Florida Obsessive-Compulsive Inventory (FOCI) | FOCI, a self-rating scale, is used to assess the severity of obsessive-compulsive symptoms within one month, which contains 20 items. The first 15 items are evaluated the symptoms by yes and no, and the last 5 items are evaluated the severity of symptoms on 0-4 five-point scale. | Change from Baseline at 6weeks | |
Secondary | Change of Self-rating Depression Scale (SDS) | Self-rating Depression Scale (SDS) was developed by William W. K. Zung of Duke University Medical School in 1965. It is one of the most widely used self-rating depression scales. It is used to measure the severity of depression and its change in treatment. | Change from Baseline at 6weeks | |
Secondary | Change of Self-rating Anxiety Scale (SAS) | The Self-rating Anxiety Scale (SAS) is very similar to the Self-rating Depression Scale (SDS) from the scale construction to the evaluation method. It is a very simple clinical tool to analyze the subjective anxiety symptoms of patients. It is suitable for adults with anxiety symptoms and has a wide range of application. | Change from Baseline at 6weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04934007 -
Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder
|
N/A | |
Recruiting |
NCT04071990 -
Family Involvement in CBGT of OCD: a Randomized Controlled Trial
|
N/A | |
Completed |
NCT02541968 -
Internet-based vs Face-to-face Cognitive Behavioural Therapy for Obsessive-compulsive Disorder
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Recruiting |
NCT05391503 -
Light Therapy for Obsessive-compulsive Disorder (OCD)
|
N/A | |
Recruiting |
NCT04539951 -
Pragmatic Trial of Obsessive-compulsive Disorder
|
Phase 2 | |
Completed |
NCT03416504 -
Methods for Managing Intrusive Thoughts
|
N/A | |
Not yet recruiting |
NCT06029738 -
Effect on Obsessive-Compulsive Beliefs and Symptoms of MCT-OCD
|
N/A | |
Recruiting |
NCT02844049 -
European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS
|
N/A | |
Terminated |
NCT02909660 -
What Are You Looking for? Psychometric and Experimental Analyses of Reassurance Seeking in Obsessive-compulsive Disorder
|
N/A | |
Completed |
NCT02911324 -
Cannabinoid Medication for Adults With OCD
|
Phase 1/Phase 2 | |
Terminated |
NCT02234011 -
A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder
|
Phase 2 | |
Completed |
NCT02217995 -
Mindfulness-Based Cognitive Therapy in a Clinical Sample of OCD Patients
|
N/A | |
Withdrawn |
NCT01953042 -
Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders
|
N/A | |
Completed |
NCT02655926 -
Deep Brain Stimulation for Severe Obsessive Compulsive Disorder
|
N/A | |
Terminated |
NCT00758966 -
Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder
|
Phase 2 | |
Completed |
NCT00742664 -
Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project
|
Phase 1/Phase 2 | |
Completed |
NCT04919785 -
Deep Brain Stimulation in Severe Obsessive-compulsive Disorder
|
N/A | |
Completed |
NCT00523718 -
Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder
|
Phase 2 | |
Completed |
NCT00074815 -
Treatment of Obsessive Compulsive Disorder in Children
|
Phase 3 |